CIBC Private Wealth Group’s Inovio Pharmaceuticals INO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $163K | Buy |
80,000
+40,000
| +100% | +$81.4K | ﹤0.01% | 1199 |
|
|
2025
Q1 | $58.4K | Buy |
+40,000
| New | +$58.4K | ﹤0.01% | 1580 |
|
|
2024
Q3 | – | Sell |
-358
| Closed | -$3.11K | – | 3199 |
|
|
2024
Q2 | $3.11K | Sell |
358
-10,000
| -97% | -$86.8K | ﹤0.01% | 2666 |
|
|
2024
Q1 | $136K | Buy |
+10,358
| New | +$136K | ﹤0.01% | 1268 |
|
|
2023
Q3 | – | Sell |
-9,926
| Closed | -$53.2K | – | 1106 |
|
|
2023
Q2 | $53.2K | Buy |
9,926
+7,167
| +260% | +$38.4K | ﹤0.01% | 858 |
|
|
2023
Q1 | $27.2K | Hold |
2,759
| – | – | ﹤0.01% | 875 |
|
|
2022
Q4 | $52 | Hold |
2,759
| – | – | ﹤0.01% | 839 |
|
|
2022
Q3 | $57K | Buy |
+2,759
| New | +$57K | ﹤0.01% | 886 |
|
|
2019
Q1 | – | Sell |
-5,375
| Closed | -$258K | – | 941 |
|
|
2018
Q4 | $258K | Buy |
+5,375
| New | +$258K | ﹤0.01% | 794 |
|